M et P Pharma AG
R&D for Intranasal Drug Delivery

M et P is a research and development company focusing on the nasal delivery of drugs, especially hormones and neurotransmitters.

The company has developed a versatile proprietary formulation and application technology. This technology provides a promising alternative to current application forms. Among others it offersincreased efficacy and/or reduced toxicity at lower doses  by avoiding first-pass effects and improved entry into the brain without re-engineering the molecule.

Applying this technology, M et P has multiple product candidates in preclinical or clinical development.